These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15592929)

  • 41. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells.
    Liu H; Pan Z; Li A; Fu S; Lei Y; Sun H; Wu M; Zhou W
    Cell Mol Immunol; 2008 Oct; 5(5):373-8. PubMed ID: 18954561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
    Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
    J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.
    Roy I; Zimmerman NP; Mackinnon AC; Tsai S; Evans DB; Dwinell MB
    PLoS One; 2014; 9(3):e90400. PubMed ID: 24594697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system.
    Dotan I; Werner L; Vigodman S; Weiss S; Brazowski E; Maharshak N; Chen O; Tulchinsky H; Halpern Z; Guzner-Gur H
    Inflamm Bowel Dis; 2010 Apr; 16(4):583-92. PubMed ID: 19774645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
    Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
    Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.
    Ying J; Xu Q; Zhang G; Liu B; Zhu L
    Med Oncol; 2012 Sep; 29(3):1716-22. PubMed ID: 21630055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
    Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
    Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
    Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
    Neve Polimeno M; Ierano C; D'Alterio C; Simona Losito N; Napolitano M; Portella L; Scognamiglio G; Tatangelo F; Maria Trotta A; Curley S; Costantini S; Liuzzi R; Izzo F; Scala S
    Cell Mol Immunol; 2015 Jul; 12(4):474-82. PubMed ID: 25363530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
    Zeelenberg IS; Ruuls-Van Stalle L; Roos E
    Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The CXCR4/CXCL12 axis in endometrial cancer.
    Gelmini S; Mangoni M; Castiglione F; Beltrami C; Pieralli A; Andersson KL; Fambrini M; Taddei GL; Serio M; Orlando C
    Clin Exp Metastasis; 2009; 26(3):261-8. PubMed ID: 19199057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
    Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
    Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
    Phillips RJ; Burdick MD; Lutz M; Belperio JA; Keane MP; Strieter RM
    Am J Respir Crit Care Med; 2003 Jun; 167(12):1676-86. PubMed ID: 12626353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 57. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis.
    Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
    Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
    Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
    Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis.
    Chen L; Chen Q; Wu Y; Zhu M; Hu J; Zhuang Z
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human melanoma metastases express functional CXCR4.
    Scala S; Giuliano P; Ascierto PA; Ieranò C; Franco R; Napolitano M; Ottaiano A; Lombardi ML; Luongo M; Simeone E; Castiglia D; Mauro F; De Michele I; Calemma R; Botti G; Caracò C; Nicoletti G; Satriano RA; Castello G
    Clin Cancer Res; 2006 Apr; 12(8):2427-33. PubMed ID: 16638848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.